MENU
BBNX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Beta Bionics (BBNX) Ownership - Who owns Beta Bionics?

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease... Show more

Details

Group
Domestic Stock Funds
Category
Health Services
Capitalization
760.31M
P/E Ratio
N/A
Total Cash
228.69M
Projected Growth
N/A
Total Debt
7.69M
Revenue
88.57M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
5.19
Total Debt/Equity
N/A
Revenue/Share
2.01 USD as % of share price

Fundamentals

BBNX
Capitalization
760M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
229M
Total Cash/Share
5.19
Total Debt
7.69M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.01%
Revenue
88.6M
ROE
N/A
Book Value
295M
P/B Ratio
2.58
Cash Flow
N/A
Earnings
-1.94
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
10.64
Current Revenue Per Employee
66633.25
Dividends Per Share - Security
N/A
EBITDA
-65.87M
Float
N/A
Float - Current
N/A
Gross Income Margin
55.48
Revenue To Assets
-36.46
Shares Held By Institutions
1.14B
Shares Outstanding - Current
44M
Total Liabilities
35.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-43.321
View a ticker or compare two or three
BBNX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BBNX showed earnings on October 28, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details